None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Women = 19 years • Invasive unilateral breast carcinoma with histological confirmation • History of invasive breast cancer • Histologically or radiologically no suspicion of distant metastases • Performance status corresponding to ECOG grade 0-2 • Tumor size clinically and radiologically = 5cm, independent of hormone receptor and HER2 status • Clinically and sonographically negative axillary lymph nodes before biopsy; core needle biopsy or fine needle aspiration of suspicious lymph node required • BCS candidate with postoperative whole-breast irradiation and adequate systemic therapy • No psychological and geographical restriction in follow-up • Written informed consent
Exclusion criteria
Exclusion criteria: • History of any cancer in the previous 5 years • Bilateral breast cancer • Invasive breast cancer treated with neoadjuvant therapy • Tumor size clinically and radiologically > 5cm • Mastectomy candidate • Pregnancy and breastfeeding • Male breast cancer • Unable to understand and fill out questionnaires
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5yr Invasive Disease Free Survival | — |
Secondary
| Measure | Time frame |
|---|---|
| 5yr Overall Survival;5yr Distant Metastasis Free Survival;Axilla Recurrence;5yr Locoregional Recurrence Rate;Adverse Events;Quality of Life | — |
Countries
Korea, Republic of
Contacts
Seoul National University Hospital